Mechanism of RIP-1 in Mediating Abeta Neurotoxicity

About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$50,000
Active Dates
July 01, 2012 - June 30, 2013
Grant ID
A2012608
Acknowledgement
Mentor(s)
Junying Yuan, PhD, Harvard Medical School
Goals
Chronic inflammation is associated with a broad spectrum of neurodegenerative diseases of aging, including Alzheimer’s disease (AD). Dr. Sonia Mazzitelli and colleagues propose a new way to investigate the connection between chronic inflammation and brain nerve-cell loss associated with AD. This research will provide relevant information to obtain a new target for a new type of therapy for AD.
Summary
Chronic inflammation is associated with a broad spectrum of neurodegenerative diseases of aging, including Alzheimer’s disease. The lack of effective therapies clearly highlights the need for more research aimed at better understanding the specific mechanisms that cause AD
Dr. Sonia Mazzitelli and colleagues propose a new way to investigate the connection between chronic inflammation and the brain nerve-cell loss associated with AD. They have identified a new target and a new inhibitor, both of which may be involved with the brain-cell death induced by inflammation in AD. These researchers will first determine exactly how the target protein contributes to cell death by inflammation; then they will use an inhibitor drug against the target protein to see if it prevents this cell death. To test their new treatment, these researchers are using animals engineered to mimic the progression of symptoms in human AD. Being able to monitor any potential side effects experienced by these mice is important in validating the activity of the new drug.
The results of this study may lead to a new direction for developing anti-inflammatory drugs for the treatment not only of AD, and potentially of other diseases influenced by inflammation. Therefore, the Mazzitelli team’s research may have an impact on other missions of BrightFocus, including finding new treatments for macular degeneration and glaucoma.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD